McKesson’s stock surged after Latitude Investment Management cited its resilient business model and long-term earnings potential in Q4 2025.
McKesson Corporation (MCK) shares climbed 50% as Latitude Investment Management highlighted its strong earnings growth and resilient drug distribution model. The stock closed at $760.57 on May 15, 2026, with a market capitalization of $91.4 billion, after trading between $637.00 and $999.00 over the past year.
Latitude’s Q4 2025 investor letter noted the firm’s focus on earnings power rather than valuation, identifying McKesson as a long-term opportunity despite short-term headwinds. The investment manager first took a position in 2022, betting on the healthcare sector’s undervalued prospects.
The one-month return for MCK was -11.46%, reflecting recent volatility, but the broader trend underscores confidence in its supply chain solutions and pharmaceutical distribution business.